Effectiveness of topiramate across age groups in elderly patients with epilepsy -: Results of an open-label, phase IV clinical trial

被引：0
|
作者：
Stefan, H.
Schreiner, A.
Kerling, F.
Kasper, B.
Schaeuble, B.
机构：
[1] Univ Erlangen Nurnberg, Epilepsy Ctr, D-8520 Erlangen, Germany
[2] Janssen Cilag GmbH, Neuss, Germany
来源：
EPILEPSIA | 2007年 / 48卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：43 / 43
页数：1
相关论文
共 50 条
  • [31] Irinotecan/capecitabine with or without bevacizumab in metastatic colorectal cancer: Results of a prospective open-label phase iv trial
    Sprinzl, M.
    Kanzler, S.
    Abdelfatah, M.
    Adami, B.
    Ehscheid, P.
    Flieger, D.
    Goedderz, W.
    Teufel, A.
    Galle, P.
    Moehler, M.
    ANNALS OF ONCOLOGY, 2007, 18 : VII44 - VII45
  • [32] Irinotecan/capecitabine with or without bevacizumab in metastatic colorectal cancer: Results of a prospective open-label phase IV trial
    Moehler, M.
    Sprinzi, M. F.
    Abdelfatah, M.
    Adami, B.
    Ehscheid, P.
    Flieger, D.
    Goedderz, W.
    Majer, C.
    Galle, P. R.
    Kanzler, S.
    ANNALS OF ONCOLOGY, 2007, 18 : 170 - 171
  • [33] ORZORA: OPEN-LABEL PHASE IV TRIAL OF OLAPARIB IN PATIENTS WITH BRCA-MUTATED OVARIAN CANCER
    Pignata, S.
    Lewis, J.
    Tchakov, I.
    Robertson, J. D.
    Morris, T.
    Jayawardene, D.
    Tyczynski, J. E.
    Hodgson, D. R.
    Mills, J.
    Di Maio, M.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2015, 25 (09) : 1469 - 1470
  • [34] Efficacy of Topiramate in Adult Patients with Symptomatic Epilepsy An Open-Label, Long-Term, Retrospective Observation
    Lu, Yang
    Yu, Weihua
    Wang, Xuefeng
    CNS DRUGS, 2009, 23 (04) : 351 - 359
  • [35] Tolerability and safety of topiramate in chinese patients with epilepsy - An open-label, long-term, prospective study
    Lu, Yang
    Wang, Xuefeng
    Li, Qihua
    Li, Jingmei
    Yan, Yong
    CLINICAL DRUG INVESTIGATION, 2007, 27 (10) : 683 - 690
  • [36] TOPIRAMATE AS ADJUNCTIVE THERAPY IN PATIENTS WITH REFRACTORY EPILEPSY - A REPORT OF A LONG-TERM, OPEN-LABEL STUDY
    COWELL, PG
    COLES, HJ
    CRAWFORD, PM
    EPILEPSIA, 1995, 36 : S152 - S152
  • [37] Open-Label Phase 2 Clinical Trial of ManNAc for GNE Myopaty
    Carrillo, Nuria
    Huizing, Marjan
    Leoyklang, Petcharat
    Quintana, Melanie
    Shrader, Joseph
    Bradley, Kennan
    Slota, Christina
    Perreault, John
    Class, Bradley
    Ciccone, Carla
    Parks, Rebecca
    Joe, Galen
    Heiss, John
    Berry, Scott
    Malicdan, May Christine
    Gahl, William
    NEUROLOGY, 2019, 92 (15)
  • [38] Cannabidiol in patients with treatment-resistant epilepsy: an open-label interventional trial
    Devinsky, Orrin
    Marsh, Eric
    Friedman, Daniel
    Thiele, Elizabeth
    Laux, Linda
    Sullivan, Joseph
    Miller, Ian
    Flamini, Robert
    Wilfong, Angus
    Filloux, Francis
    Wong, Matthew
    Tilton, Nicole
    Bruno, Patricia
    Bluvstein, Judith
    Hedlund, Julie
    Kamens, Rebecca
    Maclean, Jane
    Nangia, Srishti
    Singhal, Nilika Shah
    Wilson, Carey A.
    Patel, Anup
    Cilio, Maria Roberta
    LANCET NEUROLOGY, 2016, 15 (03): : 270 - 278
  • [39] Seizure frequency and tolerability of topiramate in patients with epilepsy previously treated with valproic acid - Results of an open-label, non-interventional study
    Schauble, Barbara
    Wettach, Joern-Roland
    Schreiner, Andreas
    EPILEPSIA, 2006, 47 : 172 - 172
  • [40] Effectiveness of autoinoculation in viral warts: A single arm, open-label, and clinical trial
    Taneja, Gargi
    Hazarika, Neirita
    Bhatia, Riti
    DERMATOLOGIC THERAPY, 2020, 33 (06)
12345